Dec 16, 2019 SOURCE: PR NewsWire
AbbVie Inc. - Form 8.1 - Statement of Stock Purchase by Director
NORTH CHICAGO, Ill., Dec. 16, 2019 /PRNewswire/ -- AbbVie issued the following forms today.
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1.
KEY
INFORMATION
Name of person dealing (Note 1)
Richard Gonzalez
--- ---
Company dealt in
AbbVie Inc.
--- ---
Class of relevant security to which the dealings being disclosed relate (Note 2) Common shares, par value
$0.01 per share
--- ---
Date
of
dealing
4 December 2019
--- ---
2.
INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 334,589 Common Shares
(0.02%)
---
(2)
Derivatives
(other
than
options) N/A
---
(3) Options and agreements to purchase/sell 932,154 options
(0.06%)
---
Total 1,266,743 (0.09%)
---
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) N/A
Class of relevant security: Long Short
---
Number (%) Number (%)
(1) Relevant securities
---
(2)
Derivatives
(other
than
options)
---
(3) Options and agreements to purchase/sell
---
Total
---
3.
DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 5)
---
Gift of common shares
4,000 common shares $0
---
(b) Derivatives transactions (other than options transactions)
Product name,
Nature of transaction
Number of relevant securities
Price per unit
e.g.
CFD
(Note 6)
(Note 7)
(Note 5)
---
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing,
selling, Number
of
name, securities
Exercise Type,
e.g. Expiry Option
money
e.g. to
which
call the
option
option
purchasing,
price
American,
date
paid/received
varying etc.
relates (Note 7)
European etc.
per unit (Note 5)
---
(ii) Exercising
Product name,
Number of securities
Exercise price per
e.g.
call
option unit (Note 5)
---
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature
of
transaction
Details Price
per
unit
(Note 8)
(if applicable) (Note 5)
---
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be
stated.
---
Is a Supplemental Form 8 attached? (Note 9) YES/NOSQRT
Date of disclosure
16 December 2019
---
Contact
name Steven L. Scrogham
---
Telephone
number
847-938-6166
---
Name
of
offeree/offeror
with
which
acting
in
concert
AbbVie Inc.
---
Specify category and nature of acting in concert status Director of AbbVie Inc.
---
View original content:http://www.prnewswire.com/news-releases/abbvie-inc---form-8-1---statement-of-stock-purchase-by-director-300975487.html
SOURCE AbbVie
